In this pilot study the investigators will evaluate the feasibility and tolerance of surgery and brain illumination thanks to the Ev-NIRT medical device, in a group of 7 de novo Parkinson's patients implanted with the innovative medical device. Patients will be monitored for 4 years
Clinical Trial for Near Infrared Endovent... - Cure Parkinson's
Clinical Trial for Near Infrared Endoventricular Illumination for Neuroprotection in Very Early Cases of Parkinson's Disease (Ev-NIRT) (Ev-N
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Wow ... surgically implanting red lights in the brain.
Not what you're looking for?
You may also like...
The naturally occurring molecule N-acetylcysteine (NAC) shows benefit in a clinical trial for Parkinson's Disease.
decreased in Parkinson's disease, as well as improvements in clinical evaluations of the patients'...
The mechanistic role of thymoquinone in Parkinson's disease: focus on neuroprotection in pre-clinical studies 2021
thymoquinone in Parkinson's disease: focus on neuroprotection in pre-clinical studies...
The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study
currently no standardized therapies for Parkinson disease (PD). Curcumin shows anti-amyloidogenic...
The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study
Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study 2022...
Related Posts
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial
Phase 3 trial of buntanetap for early-stage Parkinson’s nears end- A diet low in animal fat and rich in N-hexacosanol and fisetin is effective in reducing symptoms of Parkinson's disease 2012
- Designer DNA drug therapy for Parkinson's disease trial initiation expected in 2023
